<DOC>
	<DOCNO>NCT00006096</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know radiation therapy combine chemotherapy kill tumor cell radiation therapy alone treat cancer vulva . PURPOSE : Randomized phase III trial determine effectiveness radiation therapy without cisplatin treat patient stage I , stage II , stage III cancer vulva .</brief_summary>
	<brief_title>Radiation Therapy With Without Cisplatin Treating Patients With Stage I , Stage II , Stage III Cancer Vulva</brief_title>
	<detailed_description>OBJECTIVES : - Compare recurrence-free interval survival patient stage I , II , III , IVA squamous cell carcinoma vulva involve inguinal lymph node treat adjuvant radiotherapy without cisplatin . - Compare toxicity regimens patient . OUTLINE : This randomize , multicenter study . Patients stratify accord primary surgical resection ( yes v ) node status ( N1 v N2 ) . Patients randomize one two treatment arm . - Arm I : Patients undergo radiotherapy 5 day week 6 week . - Arm II : Patients undergo radiotherapy arm I . Patients also receive cisplatin IV 1 hour day 1 , 8 , 15 , 22 , 29 , 36 . Patients follow every 3 month 2 year every 6 month 3 year . PROJECTED ACCRUAL : A total 250 patient accrue study within 4.5 year .</detailed_description>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage I , II , III , IVA squamous cell carcinoma vulva amenable curative treatment surgery , radiotherapy , At least 1 positive inguinal and/or femoral lymph node No inoperable ( fixed ulcerating ) groin node Must require resection urethra anal sphincter achieve negative margin Must undergone vulvar biopsy bilateral inguinal/femoral lymph node dissection within 8 week randomization No metastatic disease PATIENT CHARACTERISTICS : Age : Any age Performance status : GOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3,000/mm^3 Platelet count least 100,000/mm^3 Granulocyte count least 1,500/mm^3 Hepatic : Bilirubin great 1.5 time normal SGOT great 3 time normal Alkaline phosphatase great 3 time normal Renal : Creatinine great 2.0 mg/dL Other : Not pregnant nursing Fertile patient must use effective contraception No prior invasive malignancy within past 5 year except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy Surgery : See Disease Characteristics No 8 week since prior surgery Other : No prior therapy another malignancy would preclude study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>stage I vulvar cancer</keyword>
	<keyword>stage II vulvar cancer</keyword>
	<keyword>stage III vulvar cancer</keyword>
	<keyword>stage IVB vulvar cancer</keyword>
	<keyword>squamous cell carcinoma vulva</keyword>
</DOC>